Navigation Links
Heartland Bridge Capital Takes Equity Stake in Biotech Firm HepatoChem
Date:10/13/2011

MAHWAH, N.J., Oct. 13, 2011 /PRNewswire/ -- Heartland Bridge Capital, Inc. (OTCBB:HLBC), a private equity firm focused on developing a portfolio of unique investments in emerging technologies, announced that it has made its initial funding of $100,000 in biotechnology company HepatoChem, Inc., pursuant to a definitive investment agreement to provide up to $400,000 of equity capital.

Headquartered in Cambridge, MA, HepatoChem is a privately held company that offers pharmaceutical and biotech companies a reliable and efficient means of accessing small molecule metabolites in quantities needed in the drug development process.  HepatoChem's innovative technology uses biomimetic catalysts to mimic the metabolic function of the liver.  This unique technology, developed in collaboration with Professor John Groves at Princeton University, enables the production of metabolites more quickly and with greater cost-effectiveness than any other technology currently available.

James F. Groelinger, the CEO of Heartland Bridge Capital, commented: "We are very excited to be an early investor supporting the commercial development of HepatoChem's extraordinarily innovative technology that should significantly advance the process of commercializing new drugs.  This first step in our relationship with HepatoChem could result in additional investment opportunities in important pharmaceutical developments, and we look forward to seeing this relationship grow into a key element in our overall life sciences portfolio."

Marc Bazin, HepatoChem's founder and CEO, said: "We are pleased to be the beneficiary of this agreement with Heartland Bridge Capital. This first round of financing validates the HepatoChem technology platform, which is a crucial step in the drug development process.  This initial investment into our Company should enable the commercialization of our metabolite production technology, and we see this as an important first step in deve
'/>"/>

SOURCE Heartland Bridge Capital, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Express Scripts HealthBridge Pharma & Biotech to Provide Exclusive Specialty Pharmacy Services and Limited Distribution Services for Solesta®
2. Efficacy Data from Phase III VELOUR Trial in Colorectal Cancer to be Presented at Angiogenesis Foundations 2011 M. Judah Folkman International Conference in Cambridge, Mass.
3. Medical Care Technologies Inc. Closes $200,000 Bridge Loan Financing for Kids Health Center
4. BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study
5. Clearbridge BioLoc Unveils Innovative Lab-on-Card Analysis Platform for Point-of-Care Testing at Worlds Largest Clinical Lab Conference
6. Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility
7. BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions
8. HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients
9. Cempra Pharmaceuticals to Present at Two Upcoming Cambridge Healthtech Institute (CHI) Conferences
10. BridgePoint Medical Names Industry Veteran as Chief Executive Officer
11. BridgePoint Medical Closes $9.1 Million Series C Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... COLLEGE PARK, Md. , Nov. 21, 2014 /PRNewswire-USNewswire/ ... Engineering today will host the ceremonial groundbreaking of the ... Maryland, College Park. The new building will cultivate transformative ... human health.  Taking place at 10:00 a.m. ... building in the Paint Branch Parking Lot, adjacent to ...
(Date:11/21/2014)... , Nov. 21, 2014  World Hemp Oil, an ... THC, announces they are now offering legal, organic oil ... Web type strains grown in medical marijuana states. People ... disorders, such as Parkinson,s, MS, and spinal cord injury, ... to pass, because imported CBD Oil Is legal in ...
(Date:11/21/2014)... 21, 2014 Clementia Pharmaceuticals, ... Agency (EMA) has granted Orphan Medicinal Product ... candidate, for the treatment of fibrodysplasia ossificans ... disabling genetic disease characterized by painful, recurrent ... new abnormal bone formation. This process, known ...
Breaking Medicine Technology:University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
... Utah, Oct. 29 Researchers at Thomas Jefferson University in ... published an article in the Journal of Nuclear Medicine reporting ... detect malignant breast tumors [1] . "All ... the targeted VPAC1 receptors located on the plasma membrane of ...
... Qforma, an advanced analytics and predictive modeling company, ... of director of field operations. , "Erin is a ... the latest highlight in a year marked by company growth ... "Her combined background and expertise in analytics and healthcare will ...
Cached Medicine Technology:New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors 2New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors 3Qforma Appoints Erin McLaughlin as Director, Field Operations 2
(Date:11/22/2014)... Discount-Dress.com is an important company in the dress industry. ... company’s online market share by a series of promotions. Recently, ... announced a bridesmaid dress promotion for the new year 2015. ... the dresses from this company are not only of high ... very good at manufacturing wedding dresses. Customers prefer to choose ...
(Date:11/22/2014)... TX (PRWEB) November 22, 2014 ... (ICS) as the complaint that the individual has ... for voiding. The report “Nocturia – Pipeline Review, ... development for Nocturia, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ...
(Date:11/22/2014)... New York, New York (PRWEB) November 22, 2014 ... use of power morcellators ( http://www.morcellatorlawsuit2015.com ) in ... than 450 new signatures since the end of October, ... people had signed the petition as of November 21st, ... October 31st, when 86,042 supporters had signed on to ...
(Date:11/22/2014)... Nov. 22, 2014 (HealthDay News) -- The wide variety ... pose a threat for people with food allergies, an ... are so many types of food allergies that it ... the holidays," Dr. Guha Krishnaswamy, director of allergy and ... in a hospital news release. "If you know ...
(Date:11/22/2014)... York (PRWEB) November 22, 2014 Lipitor ... behalf of patients who allegedly developed Type 2 diabetes ... the federal multidistrict litigation now underway in U.S. District ... According to court documents, the litigation will convene its ... The Court has directed Lead Counsel for Plaintiffs and ...
Breaking Medicine News(10 mins):Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3
... Among Top 30 U.S. Ministries for Third Consecutive ... Leading,humanitarian health care agency International Aid has been ... Christian Ministries for,2007. This is the third consecutive ... MinistryWatch.com is an online database that reviews ...
... IQS To Automate Supplier Scorecard Management and Lab Accreditation ... ... IQS, the leading provider of,Enterprise Quality and Compliance Management Software, ... Health International,(FHI) a non- profit organization whose mission is to improve ...
... chances of dying were 50% higher , MONDAY, Dec. 17 ... increased risk of death, according to a University of Pennsylvania ... the December issue of the Archives of Dermatology . ... skin and joints -- has been linked with a number ...
... published research exploring the benefits of patients adhering to each of the seven behaviors (also known ... healthy eating habits , physical ... medication compliance , ... healthful coping , ...
... a strong link , MONDAY, Dec. 17 (HealthDay News) ... sex during adolescence can raise the likelihood for alcohol ... on 4,700 twins in Finland. , They focused on ... the extent to which genetic and/or environmental factors influenced ...
... 17 In an,effort to help prepare ... Corporation and the United Nations Environment Programme,s,North ... a new World,Environment Day partnership and launched ... New Martinsville partner,schools., The International Children,s ...
Cached Medicine News:Health News:International Aid Named as a MinistryWatch.com 'Shining Light' Christian Ministry 2Health News:IQS Donates Quality Management Software to Family Health International 2Health News:IQS Donates Quality Management Software to Family Health International 3Health News:Severe Psoriasis Linked to Higher Death Risk 2Health News:Having Boys as Friends Can Boost Young Girls' Drinking Risk 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools 3Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools 4
... BloodTrack Courier* controls and monitors the ... of hospital refrigerators. BloodTrack Courier provides a ... your hospital network. , BloodTrack Courier electronically ... hospital environment, from its receipt of blood ...
Lasts up to 3 months , Absorbable copolymer of glycolic acid and trimethylene carbonate , Designed to provide relief from short term dry eye conditions. , Appropriate for surgery-related d...
... Proclear Multifocal are the only contact ... experienced by those with aging eyes: presbyopia ... lenses combine a superior lens design, Balanced ... made using our patented PC Technology. The ...
... Accommodating Intraocular Lens is for the treatment of ... many middle aged and older patients. , Presbyopia ... the natural lens of the eye as a ... elastic. With less elasticity, the eye has a ...
Medicine Products: